Skip to main content
. 2019 Feb 12;49(5):419–433. doi: 10.4070/kcj.2018.0341

Table 5. Clinical outcomes according to different statin initiation timing.

Variables Time (hours) Unadjusted HR Adjusted HR Propensity-score-adjusted HR
<24 (n=2,665) ≥24 (n=1,256) p value 95% CI p value 95% CI p value 95% CI p value
Model 1 (group I vs. II or III)
Cardiac death, MI or TVR 381 (14.3) 231 (18.4) 0.001 0.75 (0.64–0.88) 0.001 0.77 (0.66–0.91) 0.002 0.78 (0.64–0.94) 0.011
All-cause death 356 (13.4) 201 (16.0) 0.027 0.81 (0.68–0.96) 0.017 0.87 (0.73–1.08) 0.108 0.87 (0.71–1.07) 0.179
Cardiac death 115 (4.3) 74 (5.9) 0.032 0.71 (0.53–0.95) 0.021 0.79 (0.59–1.06) 0.115 0.74 (0.52–1.05) 0.090
Nonfatal spontaneous MI 52 (2.0) 41 (3.3) 0.012 0.59 (0.39–0.89) 0.011 0.60 (0.40–0.91) 0.015 0.48 (0.28–0.82) 0.007
TLR 215 (8.1) 121 (9.6) 0.102 0.82 (0.65–1.02) 0.074 0.82 (0.66–1.03) 0.082 0.82 (0.63–1.07) 0.137
TVR 262 (9.8) 150 (11.9) 0.044 0.80 (0.66–0.98) 0.031 0.81 (0.66–0.99) 0.036 0.83 (0.65–1.05) 0.122
Non-TVR 155 (5.8) 80 (6.4) 0.496 0.90 (0.69–1.18) 0.439 0.90 (0.69–1.18) 0.456 0.96 (0.71–1.32) 0.812
Stroke 55 (2.1) 34 (2.7) 0.207 0.75 (0.49–1.15) 0.184 0.76 (0.49–1.17) 0.207 0.69 (0.41–1.16) 0.164
Definite or probable stent thrombosis 72 (2.7) 49 (3.9) 0.043 0.68 (0.47–0.98) 0.037 0.69 (0.48–0.99) 0.045 0.51 (0.31–0.83) 0.006
Model 2 (group I or II vs. III) <48 (n=3,145) ≥48 (n=776)
Cardiac death, MI or TVR 459 (14.6) 153 (19.7) <0.001 0.72 (0.60–0.87) 0.001 0.81 (0.67–0.97) 0.022 0.69 (0.54–0.89) 0.005
All-cause death 425 (13.5) 132 (17.0) 0.012 0.78 (0.64–0.95) 0.012 0.87 (0.72–1.06) 0.173 0.89 (0.69–1.15) 0.363
Cardiac death 135 (4.3) 54 (7.0) 0.002 0.60 (0.44–0.83) 0.002 0.72 (0.52–0.99) 0.042 0.74 (0.49–0.98) 0.047
Nonfatal spontaneous MI 65 (2.1) 28 (3.6) 0.011 0.57 (0.37–0.89) 0.014 0.59 (0.38–0.92) 0.021 0.47 (0.24–0.91) 0.024
TLR 257 (8.2) 79 (10.2) 0.073 0.79 (0.61–1.02) 0.065 0.79 (0.61–1.02) 0.074 0.69 (0.49–0.98) 0.039
TVR 319 (10.1) 93 (12.0) 0.134 0.84 (0.66–1.05) 0.127 0.84 (0.67–1.06) 0.141 0.72 (0.52–0.98) 0.039
Non-TVR 180 (5.7) 55 (7.1) 0.152 0.80 (0.59–1.08) 0.150 0.84 (0.67–1.06) 0.141 1.05 (0.72–1.52) 0.815
Stroke 69 (2.2) 20 (2.6) 0.521 0.85 (0.52–1.40) 0.531 0.87 (0.53–1.44) 0.598 0.86 (0.45–1.65) 0.651
Definite or probable stent thrombosis 91 (2.9) 30 (3.9) 0.161 0.74 (0.49–1.12) 0.159 0.76 (0.50–1.15) 0.194 0.56 (0.31–1.02) 0.059
Model 3 (group I vs. II) <24 (n=2,665) 24–48 (n=480)
Cardiac death, MI or TVR 381 (14.3) 78 (16.3) 0.264 0.84 (0.66–1.07) 0.160 0.87 (0.68–1.11) 0.268 0.84 (0.61–1.16) 0.290
All-cause death 356 (13.4) 69 (14.4) 0.549 0.90 (0.69–1.16) 0.402 0.89 (0.69–1.15) 0.368 0.94 (0.67–1.32) 0.723
Cardiac death 115 (4.3) 20 (4.2) 0.883 1.00 (0.62–1.61) 0.997 0.99 (0.61–1.59) 0.953 1.06 (0.57–1.95) 0.856
Nonfatal spontaneous MI 52 (2.0) 13 (2.7) 0.283 0.69 (0.38–1.27) 0.237 0.67 (0.37–1.24) 0.203 0.45 (0.17–1.19) 0.107
TLR 215 (8.1) 42 (8.8) 0.615 0.89 (0.64–1.24) 0.500 0.94 (0.67–1.31) 0.697 0.94 (0.61–1.45) 0.775
TVR 262 (9.8) 57 (11.9) 0.172 0.79 (0.59–1.06) 0.116 0.82 (0.61–1.09) 0.177 0.80 (0.55–1.18) 0.269
Non-TVR 155 (5.8) 25 (5.2) 0.598 1.09 (0.72–1.67) 0.683 1.07 (0.70–1.64) 0.756 0.99 (0.57–1.73) 0.974
Stroke 55 (2.1) 14 (2.9) 0.240 0.68 (0.38–1.22) 0.196 0.68 (0.38–1.22) 0.190 0.77 (0.35–1.70) 0.517
Definite or probable stent thrombosis 72 (2.7) 19 (4.0) 0.131 0.66 (0.39–1.10) 0.108 0.65 (0.39–1.09) 0.100 0.57 (0.27–1.20) 0.136

Propensity-score adjusted HRs were calculated in 1,248 matched pair in model 1, 767 matched pair in model 2, and 475 matched pair in model 3.

CI = confidence interval; HR = hazard ratio; MI = myocardial infarction; TLR = target-lesion revascularization; TVR = target-vessel revascularization.